Autonomic Dysfunction
66
17
19
23
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.5%
1 terminated out of 66 trials
95.8%
+9.2% vs benchmark
12%
8 trials in Phase 3/4
22%
5 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 23 completed trials
Clinical Trials (66)
Autonomic and Renal Contributions to Hypertension With ADT
Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition
Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome
Long COVID Immune Profiling
Time-Domain Heart Rate Variability and QT Interval in Children With Epilepsy
NightWare and Cardiovascular Health in Veterans With PTSD
Contributions to Hypertension With Androgen Deprivation Therapy
SHADES Mechanistic Trial
Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction
Non-Invasive Bioelectronic Analytics
Low-intensity Focused Ultrasound and Autonomic Response
Evaluation of Sympathetic Skin Response and Its Relationship With Clinical Response to Complex Decongestive Therapy in Patients With Postmastectomy Lymphedema
The Efficacy of Aerobic Exercise Training on ANS and Endothelial Function in Compensated Cirrhosis
Non-invasive Vagus Nerve Stimulation for Chronic Musculoskeletal Pain
LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery
Cardiac Autonomic Dysfunction in Childhood Cancer Survivors
Association Between Autonomic Dysfunction and Choroidal Vascularity Index in Fibromyalgia
Autonomic Regulation of Blood Pressure and Heart Rate During Orthostasis and Exercise in Healthy and Hypertensive Individuals
Continuous and Non-invasive Measurements by Task Force® CORE/CARDIO in Autonomic Function Testing (AFT)
Noninvasive Spinal Cord Stimulation for Early SCI